Identification of 27 Novel Variants in Genes COL4A3, COL4A4, and COL4A5 in Lithuanian Families With Alport Syndrome

被引:1
作者
Cerkauskaite, Agne [1 ]
Savige, Judy [2 ]
Janonyte, Karolina [3 ]
Jeremiciute, Ieva [3 ]
Miglinas, Marius [4 ]
Kazenaite, Edita [1 ]
Laurinavicius, Arvydas [1 ]
Strupaite-Sileikiene, Rasa [4 ]
Vainutiene, Vija [5 ]
Burnyte, Birute [1 ]
Jankauskiene, Augustina [4 ]
Rolfs, Arndt [6 ]
Bauer, Peter [7 ]
Schroeder, Sabine [7 ]
Cerkauskiene, Rimante [4 ]
机构
[1] Vilnius Univ, Inst Biomed Sci, Fac Med, Vilnius, Lithuania
[2] Univ Melbourne, Royal Melbourne Hosp, Dept Med Melbourne Hlth & Northern Hlth, Parkville, Vic, Australia
[3] Vilnius Univ, Fac Med, Vilnius, Lithuania
[4] Vilnius Univ, Inst Clin Med, Fac Med, Vilnius, Lithuania
[5] Vilnius Univ Hosp Santaros Klinikos, Ctr Ear Nose & Throat Dis, Vilnius, Lithuania
[6] Univ Rostock, Albrecht Kossel Inst Neuroregenerat, Rostock, Germany
[7] CENTOGENE GmbH, Rostock, Germany
基金
英国医学研究理事会;
关键词
Alport syndrome; novel; digenic inheritance; genotype-phenotype correlation; GENOTYPE-PHENOTYPE CORRELATIONS; NATURAL-HISTORY; COL4A3/COL4A4; MUTATIONS; DIGENIC INHERITANCE; RENAL-FAILURE; DISEASE; FEATURES; IMPACT; WOMEN;
D O I
10.3389/fmed.2022.859521
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction:Alport syndrome (AS) is an inherited disorder characterized by hematuria, proteinuria, and kidney function impairment, and frequently associated with extrarenal manifestations. Pathogenic variants in COL4A5 usually cause X-linked Alport syndrome (XLAS), whereas those in the COL4A3 or COL4A4 genes are associated with autosomal dominant (AD) or recessive (AR) inheritance. To date, more than 3000 different disease-causing variants in COL4A5, COL4A3, and COL4A4 have been identified. The aim of this study was to evaluate the clinical and genetic spectrum of individuals with novel, pathogenic or likely pathogenic variants in the COL4A3-A5 genes in a previously unstudied cohort. MethodsIn this study molecular analysis by next generation sequencing (NGS) was performed on individuals from a Lithuanian cohort, with suspected AS. The presence of AS was assessed by reviewing clinical evidence of hematuria, proteinuria, chronic kidney disease (CKD), kidney failure (KF), a family history of AS or persistent hematuria, and specific histological lesions in the kidney biopsy such as thinning or lamellation of the glomerular basement membrane (GBM). Clinical, genetic, laboratory, and pathology data were reviewed. The novelty of the COL4A3-A5 variants was confirmed in the genetic variant databases (Centogene, Franklin, ClinVar, Varsome, InterVar). Only undescribed variants were included in this study. ResultsMolecular testing of 171 suspected individuals led to the detection of 99 individuals with 44 disease causing variants including 27, previously undescribed changes, with the frequency of 9/27 (33,3%) in genes COL4A5, COL4A3 and COL4A4 equally. Three individuals were determined as having digenic AS causing variants: one in COL4A3 and COL4A4, two in COL4A4 and COL4A5. The most prevalent alterations in genes COL4A3-5 were missense variants (n = 19), while splice site, frameshift, unknown variant and stop codon changes were detected more in genes COL4A4 and COL4A5 and accounted for 3, 3, 1 and 1 of all novel variants, respectively. ConclusionGenotype-phenotype correlation analysis suggested that some variants demonstrated intra-familial phenotypic variability. These novel variants represented more than half of all the variants found in a cohort of 171 individuals from 109 unrelated families who underwent testing. Our study expands the knowledge of the genetic and phenotypic spectrum for AS.
引用
收藏
页数:12
相关论文
共 37 条
  • [1] Badenas C, 2002, J AM SOC NEPHROL, V13, P1248, DOI 10.1681/ASN.V1351248
  • [2] Genotype-Phenotype Correlation in X-Linked Alport Syndrome
    Bekheirnia, Mir Reza
    Reed, Berenice
    Gregory, Martin C.
    McFann, Kim
    Shamshirsaz, Alireza Abdollah
    Masoumi, Amirali
    Schrier, Robert W.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 21 (05): : 876 - 883
  • [3] Alport syndrome: impact of digenic inheritance in patients management
    Fallerini, C.
    Baldassarri, M.
    Trevisson, E.
    Morbidoni, V.
    La Manna, A.
    Lazzarin, R.
    Pasini, A.
    Barbano, G.
    Pinciaroli, A. R.
    Garosi, G.
    Frullanti, E.
    Pinto, A. M.
    Mencarelli, M. A.
    Mari, F.
    Renieri, A.
    Ariani, F.
    [J]. CLINICAL GENETICS, 2017, 92 (01) : 34 - 44
  • [4] Unbiased next generation sequencing analysis confirms the existence of autosomal dominant Alport syndrome in a relevant fraction of cases
    Fallerini, C.
    Dosa, L.
    Tita, R.
    Del Prete, D.
    Feriozzi, S.
    Gai, G.
    Clementi, M.
    La Manna, A.
    Miglietti, N.
    Mancini, R.
    Mandrile, G.
    Ghiggeri, G. M.
    Piaggio, G.
    Brancati, F.
    Diano, L.
    Frate, E.
    Pinciaroli, A. R.
    Giani, M.
    Castorina, P.
    Bresin, E.
    Giachino, D.
    De Marchi, M.
    Mari, F.
    Bruttini, M.
    Renieri, A.
    Ariani, F.
    [J]. CLINICAL GENETICS, 2014, 86 (03) : 252 - 257
  • [5] Clinical and Genetic Features of Autosomal Dominant Alport Syndrome: A Cohort Study
    Furlano, Monica
    Martinez, Victor
    Pybus, Marc
    Arce, Yolanda
    Crespi, Jaume
    Venegas, Maria del Prado
    Bullich, Gemma
    Domingo, Andrea
    Ayasreh, Nadia
    Benito, Silvia
    Lorente, Laura
    Ruiz, Patricia
    Gonzalez, Vanesa Lopez
    Arlandis, Rosa
    Cabello, Elisa
    Torres, Ferran
    Guirado, Lluis
    Ars, Elisabet
    Torra, Roser
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2021, 78 (04) : 560 - U82
  • [6] Prevalence Estimates of Predicted Pathogenic COL4A3-COL4A5 Variants in a Population Sequencing Database and Their Implications for Alport Syndrome
    Gibson, Joel
    Fieldhouse, Rachel
    Chan, Melanie M. Y.
    Sadeghi-Alavijeh, Omid
    Burnett, Leslie
    Izzi, Valerio
    Persikov, Anton V.
    Gale, Daniel P.
    Storey, Helen
    Savige, Judy
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (09): : 2273 - 2290
  • [7] Meta-analysis of genotype-phenotype correlation in X-linked Alport syndrome: impact on clinical counselling
    Gross, O
    Netzer, KO
    Lambrecht, R
    Seibold, S
    Weber, M
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2002, 17 (07) : 1218 - 1227
  • [8] Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy
    Gross, Oliver
    Licht, Christoph
    Anders, Hans J.
    Hoppe, Bernd
    Beck, Bodo
    Toenshoff, Burkhard
    Hoecker, Britta
    Wygoda, Simone
    Ehrich, Jochen H. H.
    Pape, Lars
    Konrad, Martin
    Rascher, Wolfgang
    Doetsch, Joerg
    Mueller-Wiefel, Dirk E.
    Hoyer, Peter
    Knebelmann, Bertrand
    Pirson, Yves
    Grunfeld, Jean-Pierre
    Niaudet, Patrick
    Cochat, Pierre
    Heidet, Laurence
    Lebbah, Said
    Torra, Roser
    Friede, Tim
    Lange, Katharina
    Mueller, Gerhard A.
    Weber, Manfred
    [J]. KIDNEY INTERNATIONAL, 2012, 81 (05) : 494 - 501
  • [9] GRUNFELD JP, 1985, CLIN NEPHROL, V23, P267
  • [10] ALPORTS-SYNDROME - A REPORT OF 58 CASES AND A REVIEW OF THE LITERATURE
    GUBLER, M
    LEVY, M
    BROYER, M
    NAIZOT, C
    GONZALES, G
    PERRIN, D
    HABIB, R
    [J]. AMERICAN JOURNAL OF MEDICINE, 1981, 70 (03) : 493 - 505